Bisoprolol may increase the hypotensive activities of Polythiazide. Bisoprolol may increase the hypotensive activities of Bimatoprost. Propericiazine may increase the hypotensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Haloperidol. Etomidate may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Curcumin may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Salbutamol. The metabolism of Bisoprolol can be decreased when combined with Venlafaxine. Bisoprolol may increase the hypotensive activities of Tolazoline. The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Acemetacin. Zomepirac may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Primaquine. The risk or severity of adverse effects can be increased when Nabilone is combined with Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Levosalbutamol. Bucillamine may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Cicletanine. The risk or severity of adverse effects can be increased when Enalapril is combined with Bisoprolol. Pyridostigmine may increase the bradycardic activities of Bisoprolol. Fenoprofen may decrease the antihypertensive activities of Bisoprolol. Tolfenamic Acid may decrease the antihypertensive activities of Bisoprolol. Benoxaprofen may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Carteolol is combined with Bisoprolol. The serum concentration of Bisoprolol can be decreased when it is combined with Bosentan. Bisoprolol may increase the bradycardic activities of Poractant alfa. The metabolism of Bisoprolol can be decreased when combined with Ranolazine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Penbutolol. Bisoprolol may increase the orthostatic hypotensive activities of Bucindolol. The risk or severity of adverse effects can be increased when Pipamperone is combined with Bisoprolol. Serrapeptase may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Chloroquine. Masoprocol may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Telithromycin. Bisoprolol may increase the hypotensive activities of Efonidipine. The serum concentration of Mepivacaine can be increased when it is combined with Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Procaterol. The metabolism of Bisoprolol can be decreased when combined with Isoniazid. The serum concentration of Bisoprolol can be increased when it is combined with Mifepristone. Bisoprolol may increase the hypotensive activities of Bepridil. The metabolism of Bisoprolol can be decreased when combined with Boceprevir. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Isosorbide Mononitrate. Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Zaltoprofen may decrease the antihypertensive activities of Bisoprolol. Perphenazine may increase the hypotensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Atomoxetine. Bufexamac may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Temocapril. Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Celiprolol. Lercanidipine may increase the hypotensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Lovastatin. The metabolism of Bisoprolol can be decreased when combined with Cholecalciferol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nicotine. Bisoprolol may increase the hypotensive activities of Obinutuzumab. The risk or severity of adverse effects can be increased when Diltiazem is combined with Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Atazanavir. Metoclopramide may increase the bradycardic activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Quinapril. Choline magnesium trisalicylate may decrease the antihypertensive activities of Bisoprolol. Mizoribine may decrease the antihypertensive activities of Bisoprolol. Nitroaspirin may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nesiritide. The metabolism of Bisoprolol can be decreased when combined with Clotrimazole. Bisoprolol may increase the hypotensive activities of Nilvadipine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Hydrochlorothiazide. Bisoprolol may increase the hypotensive activities of Mibefradil. Yohimbine may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Guanethidine. Mesoridazine may increase the hypotensive activities of Bisoprolol. The serum concentration of Bisoprolol can be decreased when it is combined with Deferasirox. The risk or severity of adverse effects can be increased when Carbetocin is combined with Bisoprolol. Bisoprolol may increase the bradycardic activities of Pasireotide. Bisoprolol may increase the bradycardic activities of Rivastigmine. The serum concentration of Bisoprolol can be increased when it is combined with Fusidic Acid. Bisoprolol may decrease the bronchodilatory activities of Arbutamine. Bisoprolol may decrease the bronchodilatory activities of Arformoterol. The metabolism of Bisoprolol can be decreased when combined with Chlorpromazine. Edrophonium may increase the bradycardic activities of Bisoprolol. The risk or severity of adverse effects can be increased when Trandolapril is combined with Bisoprolol. Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Thiethylperazine may increase the hypotensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Ziprasidone. The serum concentration of Bisoprolol can be increased when it is combined with Osimertinib. The serum concentration of Bisoprolol can be decreased when it is combined with Vemurafenib. Bisoprolol may increase the hypotensive activities of Vinpocetine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Dapagliflozin. Pargyline may increase the hypotensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Darifenacin. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Empagliflozin. Ropinirole may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Thioproperazine may increase the hypotensive activities of Bisoprolol. Galantamine may increase the bradycardic activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Azilsartan medoxomil. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Pilocarpine. The risk or severity of adverse effects can be increased when Thalidomide is combined with Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Thioridazine. Moricizine may increase the hypotensive activities of Bisoprolol. Secobarbital may increase the hypotensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Clobazam. Teriflunomide may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the orthostatic hypotensive activities of Indoramin. Bisoprolol may increase the hypotensive activities of Platelet Activating Factor. The metabolism of Bisoprolol can be decreased when combined with Amodiaquine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Chlorothiazide. The serum concentration of Bupivacaine can be increased when it is combined with Bisoprolol. Guanfacine may increase the atrioventricular blocking (AV block) activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Mirabegron. Bisoprolol may increase the hypotensive activities of Naftopidil. The metabolism of Bisoprolol can be decreased when combined with Dosulepin. Caroxazone may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bisoprolol. Bisoprolol may increase the bradycardic activities of Acetyldigitoxin. The serum concentration of Bisoprolol can be increased when it is combined with Netupitant. Thiamylal may increase the hypotensive activities of Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Bambuterol. Bisoprolol may increase the bradycardic activities of Sufentanil. Bisoprolol may decrease the bronchodilatory activities of Dobutamine. Bisoprolol may increase the hypotensive activities of Bupranolol. Distigmine may increase the bradycardic activities of Bisoprolol. Bisoprolol may increase the bradycardic activities of Digitoxin. The metabolism of Bisoprolol can be increased when combined with Nevirapine. Ambenonium may increase the bradycardic activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Losartan. Triptolide may decrease the antihypertensive activities of Bisoprolol. Flurbiprofen may decrease the antihypertensive activities of Bisoprolol. Semapimod may decrease the antihypertensive activities of Bisoprolol. Paliperidone may increase the atrioventricular blocking (AV block) activities of Bisoprolol. The metabolism of Bisoprolol can be increased when combined with Rifapentine. The metabolism of Bisoprolol can be decreased when combined with Sertraline. Isocarboxazid may increase the hypotensive activities of Bisoprolol.